Highlighting the Successes of Targeting KRAS in Pancreatic Cancer

Time: 9:20 am
day: Day One


  • Exploring why the ERK MAPK cascade is the key effector driving KRAS-dependent pancreatic cancer growth
  • Understanding how the MYC oncoprotein and transcription factor is a key ERK target for ERK-dependent pancreatic cancer growth
  • Driving altered metabolic processes that support pancreatic cancer growth via the MYC Oncoprotein